CGS 16617

Known as: CGS-16617 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

libenzapril

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Cardiac and aortic effects of angiotensin converting enzyme inhibitors.
The effects of six angiotensin converting enzyme inhibitors (captopril, CGS-16617, cilazapril, enalapril, utibapril, and… (More)
Is this relevant?
1990
1990
Dissociation of changes in cardiovascular mass and performance with angiotensin-converting enzyme inhibitors in Wistar-Kyoto and spontaneously hypertensive rats.
The effects of angiotensin-converting enzyme inhibitors on cardiovascular mass and function were measured in three groups of 22… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
1989
1989
Effects of prolonged administration of the angiotensin converting enzyme inhibitor CGS 16617 in normotensive volunteers
SummaryA new, orally active angiotensin converting enzyme (ACE) inhibitor, CGS 16617, has been evaluated in normotensive subjects… (More)
Is this relevant?
1989
1989
Physiological disposition of CGS 16617 in rat, dog, and man.
The disposition and metabolism of CGS 16617 (3-[(5-amino-1-carboxy-1S-pentyl)amino],2,3,4,5-tetrahydro-2-oxo-3S-1H-1… (More)
Is this relevant?
1988
1988
Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617.
Renal actions of the new angiotensin converting enzyme inhibitor CGS 16617 were evaluated in anesthetized dogs. Intravenous… (More)
Is this relevant?
1988
1988
Effects of two nonsulfhydryl angiotensin-converting enzyme inhibitors, CGS 14831 and CGS 16617, on myocardial damage and left-ventricular hypertrophy following coronary artery occlusion in the rat.
The present study was designed to examine the effects of two new angiotensin-converting enzyme (ACE) inhibitors, CGS 14831 and… (More)
Is this relevant?
1987
1987
Additive beneficial effects of two inhibitors of vasoconstrictor mediators in acute myocardial ischemia.
A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-12970, a new angiotensin-converting enzyme (ACE) inhibitor, CGS… (More)
Is this relevant?
1987
1987
Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
The effect of a specific inhibitor of thromboxane (Tx) A2 synthesis, CGS-13080, a new angiotensin converting enzyme inhibitor… (More)
Is this relevant?
1985
1985
Effects of Food on the Bioavailability of CGS 16617, an Angiotensin‐Converting Enzyme Inhibitor, in Healthy Subjects
Pentopril (CGS 13945) was administered in 125-mg capsules to eight healthy men on two occasions according to a randomized… (More)
Is this relevant?
1985
1985
Effects of food on the bioavailability of CGS 16617, an angiotensin-converting enzyme inhibitor, in healthy subjects.
CGS 16617, a direct-acting angiotensin-converting-enzyme inhibitor, was administered as a single dose of 20 mg in aqueous… (More)
Is this relevant?